ageing, health, disability, cognition, digitalisation, infrastructure, connection
Joined October 2015
- Tweets 2,977
- Following 511
- Followers 876
- Likes 4,489
208 Photos and videos
James Rupert Fletcher retweeted
1 May 2025
@DementiaUK @alzheimerssoc @AlzResearchUK @alzassociation @mariecurieuk @DorothyHouseHC @access2care @PEoLCSW @TheAPPMuk @kingsnmpc
1
2
209
James Rupert Fletcher retweeted
5 Nov 2024
🎬 See films made with local older people, including @rxtheatre Elders & explore urban life through different eyes. Followed by friendly Q&A! @anthonyburgess on Nov 6th, 2pm. Friendly atmosphere, great conversation. Book: [eventbrite.co.uk/e/mancheste…] #McrESRCFest #ESRCFestival
5
5
681
James Rupert Fletcher retweeted
30 Oct 2024
The AWARD Network November webinar is next week! Wednesday, November 6, 9-10am PT “Utilizing VR and Robotics in Dementia" awardnetwork.ucsf.edu
2
3
765
James Rupert Fletcher retweeted
31 Oct 2024
📽️ Discover what it means to be part of the ageing urban community! Join us @anthonyburgess, 6 Nov, 2pm to explore films about life in Manchester as we age. Free entry, part of @ESRC. In collab with @MUARG1 eventbrite.co.uk/e/mancheste… #McrESRCFest #ESRCFestival
5
4
665
James Rupert Fletcher retweeted
23 Oct 2024
Donanemab is not recommended by NICE for cognitive impairment or dementia caused by Alzheimer's.
This is due to limited benefits and high costs, including monthly infusions and intensive side effect monitoring, therefore it not good use for the taxpayer: nice.org.uk/news/articles/ne…
ALT Graphic showing photo of healthcare professional looking at brain scans and the following text: New Alzheimer's treatment donanemab does not currently demonstrate value for the NHS.
5
22
25
22,125
@EisaiUS to ask Australia's @TGAgovau to reconsider rejection of Alzheimer's drug Leqembi
endpts.com/australia-rejects… via @KatherineMLewin
1
2
1,020
2 Oct 2024
⬇️only two more weeks for submissions⬇️
@isa_sociology @SocioFamilyISA
7 Aug 2024
Working on 𝐌𝐎𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒, 𝐂𝐋𝐈𝐌𝐀𝐓𝐄, 𝐅𝐀𝐌𝐈𝐋𝐈𝐄𝐒?
Submit for “Connecting Mobility Ecologies, Climate Crises and Families” @isa_sociology conference
🇲🇦Rabat, Jul 6-11, 2025🇲🇦
⏰300 word English abstracts due Oct 15⏰
isaconf.confex.com/isaconf/f…
2
1
1,082
James Rupert Fletcher retweeted
26 Sep 2024
Concerning because this work has been used to support the alpha synuclein biological definition and the value of the seed assay @pash22
Did a top NIH official manipulate Alzheimer's and Parkinson’s studies for decades? | Science | AAAS science.org/content/article/…
3
6
23
13,903
26 Sep 2024
The 1st IN-CITU paper is Open Access @socscimed
Guided by passengers with dementia on Manchester's re-municipalising bus network
We go shopping👜
We pet dogs🐕
We navigate time, disability, inequality & segregation🏙️
sciencedirect.com/science/ar…
@MCRSociology @morgancentre @MUARG1
1
9
21
1,159
This is not new news from @US_FDA , this has been going on for donkey's ears
"Financial conflicts of interest at FDA Drug Advisory Committee meetings"
drive.google.com/file/d/1-DZ… via @VPrasadMDMPH et al
1
6
21
7,591
James Rupert Fletcher retweeted
7 Aug 2024
Working on 𝐌𝐎𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒, 𝐂𝐋𝐈𝐌𝐀𝐓𝐄, 𝐅𝐀𝐌𝐈𝐋𝐈𝐄𝐒?
Submit for “Connecting Mobility Ecologies, Climate Crises and Families” @isa_sociology conference
🇲🇦Rabat, Jul 6-11, 2025🇲🇦
⏰300 word English abstracts due Oct 15⏰
isaconf.confex.com/isaconf/f…
6 Aug 2024
📣 #ISAforum25 Call for Abstracts is now open!
Review the guidelines and prepare your submission here 🌐 isa-sociology.org/en/confere…
⏰ October 15, 2024 is the final date to submit your abstract. No extensions to the deadline will be provided.
2
1
1,659
23 Sep 2024
A little late to the #WAD party but if you scroll deep down in the World Alzheimer Report 2024 you'll find a more critical stance👇
(QT because I can't reply to you for some reason!)
alzint.org/resource/world-al…
23 Sep 2024
This has been a known issue for some time - see work of @JamesRuFletcher - that, as James described, corporate charities raise awareness for themselves by blaming a lack of awareness about dementia, which they also say is responsible for stigma.
2
3
5
1,125
20 Sep 2024
Always love an @WankaAnna workshop✂️📸
So much great digital ageing work (& fun) @ socio-gerontechnology 2024 @socgerontech @MattLariv @wendymartin007 @juliane_jarke
20 Sep 2024
Excited to be at the @socgerontech conference in Vienna 🌞
Great morning spent workshopping and visualizing the relationality of age(ing) and technology 🤖
1
8
545
James Rupert Fletcher retweeted
14 Sep 2024
‘The data on extreme human ageing is rotten from the inside out’ – Saul Justin Newman. Best morning read. theconversation.com/the-data…
2
2
234
23 Aug 2024
Frustrating morning of radio coverage based entirely on charity talking heads, disappointment and "hope"
Haven't heard anything about the drug, its risks/benefits or cost implications
Debate rages over Alzheimer’s drug lecanemab as UK's @NICEComms limits approval: The medicine is being assessed by agencies including the European Union regulator, but the community is divided on its efficacy and safety. nature.com/articles/d41586-0… via @DianaMKwon
1
6
10
2,289
@NHSEngland & @WGHealthandCare 's cost-effectiveness agency @NICEComms gives negative review of Alzheimer’s drug Leqembi: The treatment from Eisai and Biogen has hit another roadblock in reaching patients in Europe
statnews.com/2024/08/22/uk-l… via @DrewQJoseph
2
2
5
1,044
Eisai said in its own release that it is working with NICE, the Scottish Medicines Consortium and the NHS to make Leqembi available “as soon as possible.”
endpts.com/biogen-eisais-leq… via @Ayisha_Sharma97
3
3
7
1,101